Shattuck Labs (STTK) Revenue (2019 - 2025)
Shattuck Labs (STTK) posted quarterly Revenue of $1.0 million for Q3 2025, down 66.63% year-over-year from $3.0 million in Q3 2024, and down 66.63% quarter-over-quarter from $3.0 million in Q3 2024.
Shattuck Labs (STTK) Revenue (2019 - 2025) Analysis & Trends
Shattuck Labs (STTK) has reported Revenue for 7 consecutive years, with $1.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Revenue fell 66.63% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (down 78.29% YoY), while the FY2025 annual figure was $1.0 million, down 82.52% from the prior year.
- Revenue retreated to $1.0 million in Q3 2025 per STTK's latest filing, from $3.0 million in the prior quarter.
- Across five years, Revenue topped out at $30.0 million in Q4 2021 and bottomed at $50000.0 in Q2 2022.
- Historically, Revenue has averaged $3.2 million across 5 years, with a median of $1.0 million in 2025.
- Annual changes were most pronounced in 2021 — Revenue jumped 2132.19% — and 2022, when it tumbled 98.82%.
- Shattuck Labs' Revenue stood at $30.0 million in 2021, then slumped by 98.7% to $390000.0 in 2022, then jumped by 83.08% to $714000.0 in 2023, then jumped by 319.75% to $3.0 million in 2024, then sank by 66.63% to $1.0 million in 2025.
- Business Quant data shows STTK's Revenue at $1.0 million in Q3 2025, $3.0 million in Q3 2024, and $1.6 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 714,000.00 |
| Sep 30, 2023 | 686,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 390,000.00 |
| Sep 30, 2022 | 212,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Dec 31, 2021 | 29.96 Mn |
| Sep 30, 2021 | 1.90 Mn |
| Jun 30, 2021 | 4.23 Mn |
| Mar 31, 2021 | 2.27 Mn |
| Dec 31, 2020 | 1.34 Mn |
| Sep 30, 2020 | 2.44 Mn |
| Jun 30, 2020 | 3.18 Mn |
| Mar 31, 2020 | 2.98 Mn |
| Dec 31, 2019 | 2.82 Mn |